A clinician-guided decision
Resolve offers Wegovy as an option for patients throughout Georgia when a provider determines it is medically appropriate.
In the clinical study cited on Resolve’s previous site, treatment with Wegovy was associated with statistically significant body-weight reduction compared with placebo at 68 weeks. Your clinician will help you understand the benefits, risks and fit for your individual history.
For further independent medication information, visit Wegovy resources.